Soliton Announces Successful Completion of Safety Testing at SGS to Support FDA Filing for Second Generation Device Dec 18, 2019
Soliton Announces First Follow-up Visit Conducted in the Pivotal Cellulite Clinical Trial Nov 12, 2019
Soliton Announces Positive Interim Clinical Trial Results with 27% Average Reduction in Scar Volume From Single Non-Invasive Treatment Oct 25, 2019
Soliton to Announce Keloid Trial Data on October 25, 2019 and Host Webcast at 5:30PM ET to Discuss Results Oct 21, 2019
